Protein energy malnutrition differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(17 intermediate revisions by 4 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Protein energy malnutrition}}
[[Image:Home_logo1.png|right|250px|link=https://www.wikidoc.org/index.php/Protein_energy_malnutrition]]


{{CMG}}; {{AE}} {{DAMI}}
{{CMG}}; {{AE}} {{DAMI}}


==Overview==
==Overview==
Protein energy malnutrition must be differentiated from other [[diseases]] that cause [[failure to thrive]], [[edema]], [[wasting]] [[Infections|recurrent infections]], [[skin]] and [[hair]] changes. It is important to also differentiate [[kwashiorkor]] from [[marasmus]] as the two [[diseases]] belong to the protein energy malnutrition.
Protein energy malnutrition must be differentiated from other [[diseases]] that cause [[failure to thrive]], [[edema]], [[wasting]] [[Infections|recurrent infections]], [[skin]] and [[hair]] changes. It is important to also differentiate [[kwashiorkor]] from [[marasmus]] as the two [[diseases]] are caused by protein-energy malnutrition and share similar features such as, [[weight loss]], muscle wasting, low blood glucose levels and growth retardation.


==Differentiating Protein energy malnutrition from other Diseases==
==Differentiating Protein Energy Malnutrition From Other Diseases==


'''Differentiating kwashiorkor from marasmus<ref name="pmid16076825">{{cite journal |vauthors=Müller O, Krawinkel M |title=Malnutrition and health in developing countries |journal=CMAJ |volume=173 |issue=3 |pages=279–86 |year=2005 |pmid=16076825 |pmc=1180662 |doi=10.1503/cmaj.050342 |url=}}</ref>'''
'''Differentiating kwashiorkor from marasmus'''
 
[[Kwashiorkor]] must be differentiated from [[marasmus]] as the two [[diseases]] are caused by protein-energy malnutrition and share similar features such as, [[weight loss]], [[muscle wasting]], low [[blood]] [[glucose]] levels and growth retardation. The followwing table differentiates between the two:'''<ref name="pmid16076825">{{cite journal |vauthors=Müller O, Krawinkel M |title=Malnutrition and health in developing countries |journal=CMAJ |volume=173 |issue=3 |pages=279–86 |year=2005 |pmid=16076825 |pmc=1180662 |doi=10.1503/cmaj.050342 |url=}}</ref>'''<ref name="pmid20345018">{{cite journal |vauthors=Manary MJ, Heikens GT, Golden M |title=Kwashiorkor: more hypothesis testing is needed to understand the aetiology of oedema |journal=Malawi Med J |volume=21 |issue=3 |pages=106–7 |year=2009 |pmid=20345018 |pmc=3717490 |doi= |url=}}</ref><ref name="pmid8275214">{{cite journal |vauthors=Henry FJ, Briend A, Fauveau V, Huttly SA, Yunus M, Chakraborty J |title=Gender and age differentials in risk factors for childhood malnutrition in Bangladesh |journal=Ann Epidemiol |volume=3 |issue=4 |pages=382–6 |year=1993 |pmid=8275214 |doi= |url=}}</ref><ref name="pmid25223408">{{cite journal |vauthors=Coulthard MG |title=Oedema in kwashiorkor is caused by hypoalbuminaemia |journal=Paediatr Int Child Health |volume=35 |issue=2 |pages=83–9 |year=2015 |pmid=25223408 |pmc=4462841 |doi=10.1179/2046905514Y.0000000154 |url=}}</ref><ref name="pmid14436226">{{cite journal |vauthors=RAO KS, SWAMINATHAN MC, SWARUP S, PATWARDHAN VN |title=Protein malnutrition in South India |journal=Bull. World Health Organ. |volume=20 |issue= |pages=603–39 |year=1959 |pmid=14436226 |pmc=2537781 |doi= |url=}}</ref><ref name="pmid2077461">{{cite journal |vauthors=Barus ST, Rani R, Lubis NU, Hamid ED, Tarigan S |title=Clinical features of severe malnutrition at the pediatric ward of Dr. Pirngadi Hospital Medan |journal=Paediatr Indones |volume=30 |issue=11-12 |pages=286–92 |year=1990 |pmid=2077461 |doi= |url=}}</ref><ref name="pmid21695035">{{cite journal |vauthors=Rodríguez L, Cervantes E, Ortiz R |title=Malnutrition and gastrointestinal and respiratory infections in children: a public health problem |journal=Int J Environ Res Public Health |volume=8 |issue=4 |pages=1174–205 |year=2011 |pmid=21695035 |pmc=3118884 |doi=10.3390/ijerph8041174 |url=}}</ref><ref name="pmid1764353">{{cite journal |vauthors=Latham MC |title=The dermatosis of kwashiorkor in young children |journal=Semin Dermatol |volume=10 |issue=4 |pages=270–2 |year=1991 |pmid=1764353 |doi= |url=}}</ref><ref name="pmid3120652">{{cite journal |vauthors=McLaren DS |title=Skin in protein energy malnutrition |journal=Arch Dermatol |volume=123 |issue=12 |pages=1674–1676a |year=1987 |pmid=3120652 |doi= |url=}}</ref><ref name="pmid4297407">{{cite journal |vauthors=Jaya Rao KS, Srikantia SG, Gopalan C |title=Plasma cortisol levels in protein-calorie malnutrition |journal=Arch. Dis. Child. |volume=43 |issue=229 |pages=365–7 |year=1968 |pmid=4297407 |pmc=2019952 |doi= |url=}}</ref><ref name="pmid12011921">{{cite journal |vauthors=Muniz-Junqueira MI, Queiroz EF |title=Relationship between protein-energy malnutrition, vitamin A, and parasitoses in living in Brasília |journal=Rev. Soc. Bras. Med. Trop. |volume=35 |issue=2 |pages=133–41 |year=2002 |pmid=12011921 |doi= |url=}}</ref><ref name="pmid8862482">{{cite journal |vauthors=Donnen P, Brasseur D, Dramaix M, Vertongen F, Ngoy B, Zihindula M, Hennart P |title=Vitamin A deficiency and protein-energy malnutrition in a sample of pre-school age children in the Kivu Province in Zaire |journal=Eur J Clin Nutr |volume=50 |issue=7 |pages=456–61 |year=1996 |pmid=8862482 |doi= |url=}}</ref>
{| class="wikitable"
{| class="wikitable"
!Distinguishing Features
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Distinguishing Features
![[Kwashiorkor]]
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Kwashiorkor
![[Marasmus]]
! align="center" style="background:#4479BA; color: #FFFFFF;" + |Marasmus
|-
|-
|Cause
|Cause
Line 36: Line 38:
|-
|-
|[[Skin changes]]
|[[Skin changes]]
|[[Dermatitis]] and [[Hyperpigmentation]] noticed
|[[Dermatitis]] and [[hyperpigmentation]] noticed
|[[Xerostomia|Dry]] and [[atrophic]] [[skin]] but no changes in [[color]]
|[[Xerostomia|Dry]] and [[atrophic]] [[skin]] but no changes in [[color]]
|-
|-
Line 53: Line 55:
|Facial appearance
|Facial appearance
|[[Moon face|Moon-like face]]
|[[Moon face|Moon-like face]]
|Elderly man face
|Sunken eyes, [[maxillary]] prominence, loss of [[buccal]] [[fat pad]]
|-
|-
|[[Abdomen]]
|[[Abdomen]]
Line 83: Line 85:
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Kwashiorkor]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Kwashiorkor]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Deficiency of [[protein]]-rich foods like meat and [[poultry]] in diet
* Deficiency of [[protein]]-rich foods like meat and [[poultry]] in [[diet]]
* Early [[weaning]]
* Early [[weaning]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
Line 103: Line 105:
* Balanced diet of [[carbohydrates]], [[protein]] and [[fat]]
* Balanced diet of [[carbohydrates]], [[protein]] and [[fat]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[CBC]]
* [[Complete blood count]] ([[Complete blood count|CBC]])
* [[ABG]]
* [[Arterial blood gas]] ([[ABG]])
* BUN:Cr
* [[BUN-to-creatinine ratio|Blood urea nitrogen to creatnine ratio]]
* Serum [[potassium]]
* [[Serum]] [[potassium]]
* Total [[protein]]
* Total [[protein]]
* [[Urinalysis]]
* [[Urinalysis]]
Line 113: Line 115:
* [[Lipiduria]] and [[ketonuria]] portend a poorer prognosis
* [[Lipiduria]] and [[ketonuria]] portend a poorer prognosis
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Caloric replacement
* [[Calorie|Caloric]] replacement
* [[Protein]] replacement
* [[Protein]] replacement
* [[Vitamin]] and [[mineral]] supplementation
* [[Vitamin]] and [[mineral]] supplementation
* [[Antibiotics]] if infections are present
* [[Antibiotics]] if [[infections]] are present
* Plasma expanders and [[ORS]], if shock is present
* [[Plasma]] expanders and [[Oral rehydration therapy|oral rehydration solution]] ([[Oral rehydration therapy|ORS]]), if [[shock]] is present
* [[Lactase]] if [[lactose intolerant]]  
* [[Lactase]] if [[lactose intolerant]]  
|-
|-
Line 133: Line 135:
* [[Hypothermia|Hypo]] / [[hyperthermia]]
* [[Hypothermia|Hypo]] / [[hyperthermia]]
* [[Dehydration]]
* [[Dehydration]]
* Skin pallor
* [[Skin]] [[pallor]]
* [[Anemia]]
* [[Anemia]]
* [[Corneal disease|Corneal lesions]] (due to [[vitamin A deficiency]])
* [[Corneal disease|Corneal lesions]] (due to [[vitamin A deficiency]])
* Decreased distal pulses  
* Decreased peripheral pulses  
* [[Confusion]]
* [[Confusion]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
Line 145: Line 147:
* [[Peripheral blood smear]]
* [[Peripheral blood smear]]
* [[Hemoglobin]]
* [[Hemoglobin]]
* [[Urinalysis]] and culture
* [[Urinalysis]] and [[Culture collection|culture]]
* [[Stool examination|Stool exam]]
* [[Stool examination|Stool exam]]
* [[Serum albumin|Albumin tests]]
* [[Serum albumin|Albumin tests]]
* [[Electrolyte|Electrolyte level]]
* [[Electrolyte|Electrolyte level]]
| style="background: #DCDCDC; padding: 5px;" | :
| style="background: #DCDCDC; padding: 5px;" | :
* Prognosis is  good if underlying medical illness is treated   
* [[Prognosis]] is  good if underlying medical illness is treated   
* [[Bacterial infection]] and [[renal failure]] may portend a poorer prognosis  
* [[Bacterial infection]] and [[renal failure]] may portend a poorer [[prognosis]]
| style="background: #F5F5F5; padding: 5px;" | :
| style="background: #F5F5F5; padding: 5px;" | :
* [[Blood glucose]] control
* [[Blood glucose]] control
* Prevent [[hypothermia]]
* [[Prevention (medical)|Prevent]] [[hypothermia]]
* Prompt correction of [[dehydration]]
* Prompt correction of [[dehydration]]
* Early detection and correction of [[electrolyte imbalance]]
* Early detection and correction of [[electrolyte imbalance]]
* Active control of [[infections]]
* Active control of [[infections]]
* Screening and stabilization of [[Micronutrient malnutrition|micronutrient deficiencies]]
* [[Screening (medicine)|Screening]] and stabilization of [[Micronutrient malnutrition|micronutrient deficiencies]]
* Feeding for initial stabilization
* Feeding for initial stabilization
* [[Nutritional supplement|Nutritional support]] to support normal growth
* [[Nutritional supplement|Nutritional support]] to support normal growth
Line 181: Line 183:
* Avoidance of [[infections]] and other [[diseases]] associated with [[protein losing enteropathy]]
* Avoidance of [[infections]] and other [[diseases]] associated with [[protein losing enteropathy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Measurement of [[albumin]] / [[globulin]] levels
* Measurement of [[albumin]]/[[globulin]] levels


* Presence of [[Alpha 1-antitrypsin deficiency|α1-antitrypsin]] in stool samples
* Presence of [[Alpha 1-antitrypsin deficiency|α1-antitrypsin]] in [[stool]] samples
* Measuremnent of [[Vitamin A Deficiency|vitamins A]], [[Vitamin D Deficiency|D]], [[Vitamin E deficiency|E]] and [[Vitamin K Deficiency|K]]
* Measuremnent of [[Vitamin A Deficiency|vitamins A]], [[Vitamin D Deficiency|D]], [[Vitamin E deficiency|E]] and [[Vitamin K Deficiency|K]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Prognosis largely depends on the [[Disease|underlying disease]]
* [[Prognosis]] largely depends on the [[Disease|underlying disease]]
* If it is potentially curable, prognosis improves considerably
* If it is potentially curable, [[prognosis]] improves considerably
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Antiparasitics|Antiparasitic agents]]
* [[Antiparasitics|Antiparasitic agents]]
Line 204: Line 206:
| style="background: #F5F5F5; padding: 5px;" | 1-4
| style="background: #F5F5F5; padding: 5px;" | 1-4
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[Generalized edema]] of body tissues with profound subcutaneous [[Edema|swelling]]
* [[Generalized edema]] of body tissues with profound [[subcutaneous]] [[Edema|swelling]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Healthy [[balanced diet]] in children
* Healthy [[balanced diet]] in children
* Treatment of underlying [[Heart failure|heart problems]]
* Treatment of underlying [[Heart failure|heart problems]]
* Treatment of cancers
* Treatment of [[Cancer|cancers]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* CBC
* [[CBC]]
* ABG
* [[ABG]]
* BNP
* [[Brain natriuretic peptide]] ([[BNP]])
* BUN:Cr
* [[BUN-to-creatinine ratio|BUN:Cr]]
* Serum potassium
* [[Serum potassium]]
* Total protein
* [[Total protein]]
* Urinalysis
* [[Urinalysis]]
| style="background: #DCDCDC; padding: 5px;" | Good prognosis if the underlying cause is identified and treated early
| style="background: #DCDCDC; padding: 5px;" | Good [[prognosis]] if the underlying cause is identified and treated early
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Treatment is targetted at the underlying cause
* Treatment is targeted at the underlying cause
* Diuretics if due to fluid overload
* [[Diuretics]] if due to [[fluid overload]]
* Albumin infusion to correct hypoproteinemia
* [[Albumin]] [[infusion]] to correct [[hypoproteinemia]]
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''HIV wasting syndrome'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Wasting syndrome|HIV wasting syndrome]]
| style="background: #DCDCDC; padding: 5px;" | HIV infection
| style="background: #DCDCDC; padding: 5px;" | [[HIV AIDS|HIV infection]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* All age groups
* All age groups
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* >10% total body weight loss  
* >10% total body [[weight loss]]
* Severe diarrhea
* [[Chronic diarrhea|Severe diarrhea]]
* Chronic weakness
* Chronic [[weakness]]
* Fever lasting for more than three to four weeks
* Fever lasting for more than three to four weeks
* HIV infection
* [[HIV AIDS|HIV infection]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Use of HAART
* Use of [[AIDS antiretroviral drugs|HAART]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Nutritional assessment
* Nutritional assessment
* Serial measurements of weight
* Serial measurements of [[weight]]
* Body mass index (BMI)  
* [[Body mass index]] ([[BMI]])  
* Evaluate LBM,
* [[Body water|Total body water]] and [[fat]]
* Total body water and fat
* Sequential [[anthropometry]] (mid arm circumference, [[triceps]], skinfold thickness) to predict [[prognosis]]
* Sequential anthropometry (mid arm circumference, triceps skinfold thickness) to predict prognosis
| style="background: #DCDCDC; padding: 5px;" | [[Prognosis]] is good with the use of [[HIV AIDS medical therapy|highly active anti-retroviral therapy]] ([[HIV AIDS medical therapy|HAART]])
| style="background: #DCDCDC; padding: 5px;" | Prognosis is good with the use of HAART  
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* HAART
* [[AIDS antiretroviral drugs|HAART]]
* Megestrol acetate
* [[Megestrol acetate]]
* Marijuana (in some states)
* [[Marijuana]] (in some states)
* Dronabinol
* [[Dronabinol]]
* Somatropin
* [[Somatropin]]
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | Congenital heart disease
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Chronic pancreatitis]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''Chronic pancreatitis'''
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Tumors or stones
* [[Tumors]] or [[Kidney stone|stones]]
* Toxic metabolites  
* [[Metabolites|Toxic metabolites]]
* Necrosis
* [[Necrosis]]
* Fibrosis
* [[Fibrosis]]
* Oxidative stress
* [[Oxidative stress]]
* Ischemia
* [[Ischemia]]
* Alcohol consumption
* [[Alcohol consumption]]
* Autoimmune disorders
* [[Autoimmune disorders]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* 30 to 40 years
* 30 to 40 years
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Epigastric abdominal pain
* [[Epigastric pain|Epigastric abdominal pain]]
* Nausea
* [[Nausea]]
* Vomiting
* [[Vomiting]]
* Decreased appetite
* [[Decreased appetite]]
* Exocrine and endocrine dysfunction
* [[Exocrine]] and [[Endocrine disease|endocrine dysfunction]]
* Weight loss
* [[Weight loss]]
* Protein deficiency
* [[Protein deficiency]]
* Diarrhea and steatorrhoea
* [[Diarrhea]] and [[steatorrhoea]]
* Secondary diabetes mellitus
* Secondary [[diabetes mellitus]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Avoiding alcohol can reduce the risk for the development of chronic pancreatitis.
* Avoiding [[alcohol]] can reduce the risk for the development of [[chronic pancreatitis]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Pancreatic enzymes
* [[Pancreatic]] [[enzymes]]
* Blood sugar
* [[Blood sugar]]
* Stool analysis for presence of enzymes and fat
* [[Stool examination|Stool analysis]] for presence of [[enzymes]] and [[fat]]
* Computerized tomography
* [[Computed tomography|Computerized tomography]]
* X-rays
* [[X-rays]]
* Magnetic resonance cholangiopancreatography
* [[Magnetic resonance cholangiopancreatography]]
* Transabdominal ultrasound
* [[Ultrasonic Imaging|Transabdominal ultrasound]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Patients who get medical care early have a good prognosis
* Patients who get medical care early have a good [[prognosis]]
* increased risk of pancreatic cancer
* Increased risk of [[pancreatic cancer]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Ibuprofen and acetaminophen along with antioxidants
* [[Ibuprofen]] and [[acetaminophen]] along with [[antioxidants]]
* Surgical options are considered if medical options fail
* [[Surgery operation|Surgical options]] are considered if [[Medical therapy template|medical options]] fail
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | '''Pediatric nephrotic syndrome'''
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Nephrotic syndrome|Pediatric nephrotic syndrome]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Glomerular lesions such as minimal change nephrotic syndrome
* [[Glomerular disease|Glomerular lesions]] such as [[Minimal change GN|minimal change nephrotic syndrome]]
* Secondary nephrotic syndromes
* Secondary [[Nephrotic syndrome|nephrotic syndromes]]
* Genetic abnormalities such as infantile nenphrotic syndromes
* [[Genetics|Genetic abnormalities]] such as [[Nephrotic syndromes|infantile nephrotic syndromes]]
* Infections
* [[Infections]]
* Drugs
* [[Drugs]]
| style="background: #F5F5F5; padding: 5px;" | <16years
| style="background: #F5F5F5; padding: 5px;" | <16years
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Nephrotic-range proteinuria
* [[Proteinuria|Nephrotic-range proteinuria]]
* Edema
* [[Edema]]
* Hyperlipidemia,
* [[Hyperlipidemia]]
* Hypoalbuminemia
* [[Hypoalbuminemia]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Avoid infections and drugs that may predispose to nephrotic syndrome
* Avoid [[infections]] and [[drugs]] that may predispose to [[nephrotic syndrome]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Urinalysis
* [[Urinalysis]]
* Urine protein quantification (by first-morning urine protein/creatinine or 24-hour urine protein)
* [[Urine catecholamines|Urine protein]] quantification (by first-morning [[urine]] [[protein]] / [[creatinine]] or 24-hour urine protein)
* Serum albumin
* [[Serum albumin]]
* Lipid panel
* [[Lipid|Lipid panel]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Prognosis depends on whether the nephrotic syndrome is steroid responsive or steroid resistant
* [[Prognosis]] depends on whether the [[nephrotic syndrome]] is [[Steroid responsive nephrotic syndrome|steroid responsive]] or [[steroid]] resistant
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Corticosteroids
* [[Corticosteroids]]
* Diuretics
* [[Diuretics]]
* Antihypertensive agents
* [[Antihypertensive agents]]
* Alkylating agents
* [[Alkylating agent|Alkylating agents]]
* Calcineurin inhibitors
* [[Calcineurin inhibitor|Calcineurin inhibitors]]
* Home monitoring of urine protein and fluid status
* Home monitoring of [[urine]] [[protein]] and fluid status
|-
|-
| style="background: #F5F5F5; padding: 5px; text-align: center;" | Portal cirrhosis
| style="background: #F5F5F5; padding: 5px; text-align: center;" | [[Liver cirrhosis|Portal cirrhosis]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Hepatitis C (26%)
* [[Hepatitis C]] (26%)
* Alcoholic liver disease (21%)
* [[Alcoholic liver disease]] (21%)
* Hepatitis C plus alcoholic liver disease (15%)
* [[Hepatitis C]] plus [[alcoholic liver disease]] (15%)
* Cryptogenic causes (18%) - Many cases actually are due to NAFLD
* [[Cryptogenic cirrhosis|Cryptogenic]] causes (18%) - Many cases actually are due to [[NAFLD]]
* Hepatitis B - May be coincident with          hepatitis D (15%)
* [[Hepatitis B]] - May be coincident with          [[hepatitis D]] (15%)
* Miscellaneous (5%)
* Miscellaneous (5%)
| style="background: #F5F5F5; padding: 5px;" | 5th - 6th decade of life
| style="background: #F5F5F5; padding: 5px;" | 5th - 6th decade of life
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Hepatomegaly
* [[Hepatomegaly]]
* Abdominal pain
* [[Abdominal pain]]
* Ascites
* [[Ascites]]
* Abdominal distension
* [[Abdominal distension]]
* Bulging flanks
* [[Bulging flanks]]
* Shifting dullness
* [[Shifting dullness]]
* Puddle sign
* [[Puddle sign]]
| style="background: #DCDCDC; padding: 5px;" |
| style="background: #DCDCDC; padding: 5px;" |
* Avoid alcohol
* Avoid [[alcohol]]
* Treatment and vaccination against hepatitis
* Treatment and [[vaccination]] against [[hepatitis]]
* Good diet and exercise
* Good [[diet]] and exercise
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* CBC
* [[Complete blood count|CBC]]
* Albumin
* [[Albumin]]
* Culture
* [[Culture collection|Culture]]
* Total protein
* [[Total protein]]
* Serum ascites albumin gradient
* [[Serum-ascites albumin gradient|Serum ascites albumin gradient]]
* Ammonia level
* [[Ammonia production|Ammonia level]]
*
| style="background: #DCDCDC; padding: 5px;" | Prognosis is poor
| style="background: #DCDCDC; padding: 5px;" | Prognosis is poor
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Prednisone and azathioprine - For autoimmune hepatitis
* [[Prednisone]] and [[azathioprine]] - For [[autoimmune hepatitis]]
* Interferon and other antiviral agents - For hepatitis B and C
* [[Interferon]] and other [[Antiviral|antiviral agents]] - For [[hepatitis B]] and [[Hepatitis C|C]]
* Phlebotomy - For hemochromatosis
* [[Phlebotomy]] - For [[hemochromatosis]]
* Ursodeoxycholic acid - For primary biliary cirrhosis
* [[Ursodeoxycholic acid]] - For [[primary biliary cirrhosis]]
* Trientine and zinc - For Wilson disease
* [[Trientine]] and [[zinc]] - For [[Wilson disease]]
* Liver transplantation
* [[Liver transplantation]]
|}
|}
<small>Table adapted from CDC Pinkbook.<ref name="CDC90">{{cite web | title = Epidemiology and Prevention of Vaccine-Preventable Diseases | url = http://www.cdc.gov/vaccines/pubs/pinkbook/table-of-contents.html }}</ref></small>
<small>Table adapted from CDC Pinkbook.<ref name="CDC90">{{cite web | title = Epidemiology and Prevention of Vaccine-Preventable Diseases | url = http://www.cdc.gov/vaccines/pubs/pinkbook/table-of-contents.html }}</ref></small>

Latest revision as of 22:36, 25 February 2019

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Omodamola Aje B.Sc, M.D. [2]

Overview

Protein energy malnutrition must be differentiated from other diseases that cause failure to thrive, edema, wasting recurrent infections, skin and hair changes. It is important to also differentiate kwashiorkor from marasmus as the two diseases are caused by protein-energy malnutrition and share similar features such as, weight loss, muscle wasting, low blood glucose levels and growth retardation.

Differentiating Protein Energy Malnutrition From Other Diseases

Differentiating kwashiorkor from marasmus

Kwashiorkor must be differentiated from marasmus as the two diseases are caused by protein-energy malnutrition and share similar features such as, weight loss, muscle wasting, low blood glucose levels and growth retardation. The followwing table differentiates between the two:[1][2][3][4][5][6][7][8][9][10][11][12]

Distinguishing Features Kwashiorkor Marasmus
Cause Deficiency of protein in the diet of child Deficiency of protein as well as energy nutrients (that is carbohydrates and fats) in the diet
Age Occurs in children in the age group 1-5 years Typically occurs in children below the age of 1 year
Association More common in villages where there is small gap period between successive pregnancies More common in towns and cities where breast-feeding in discontinued quite early
Edema Presence of edema Absence of edema
Muscles Wasting of muscles Wasting of muscles is quite evident. The child is reduced to skin and bones
Skin changes Dermatitis and hyperpigmentation noticed Dry and atrophic skin but no changes in color
Serum cortisol Decreased/Normal Increased
Fasting blood glucose Decreased Decreased
Growth retardation Mildly retarded in growth Severely retarded in growth
Facial appearance Moon-like face Sunken eyes, maxillary prominence, loss of buccal fat pad
Abdomen Protuded Shrunken
Vitamin deficiency Present Present
Weight 60-80% of normal weight for age <60% of normal weight for age

Differential diagnosis of edema and wasting [13][14][15][16][17][18][19][20]

Disease Cause Age(years) Presentation Prevention Workup Prognosis Treatment
Kwashiorkor
  • < 1
Marasmus
  • < 5
: :
Protein losing enteropathy
  • All age groups
Anasarca 1-4 Good prognosis if the underlying cause is identified and treated early
HIV wasting syndrome HIV infection
  • All age groups
Prognosis is good with the use of highly active anti-retroviral therapy (HAART)
Chronic pancreatitis
  • 30 to 40 years
Pediatric nephrotic syndrome <16years
Portal cirrhosis 5th - 6th decade of life Prognosis is poor

Table adapted from CDC Pinkbook.[21]

References

  1. Müller O, Krawinkel M (2005). "Malnutrition and health in developing countries". CMAJ. 173 (3): 279–86. doi:10.1503/cmaj.050342. PMC 1180662. PMID 16076825.
  2. Manary MJ, Heikens GT, Golden M (2009). "Kwashiorkor: more hypothesis testing is needed to understand the aetiology of oedema". Malawi Med J. 21 (3): 106–7. PMC 3717490. PMID 20345018.
  3. Henry FJ, Briend A, Fauveau V, Huttly SA, Yunus M, Chakraborty J (1993). "Gender and age differentials in risk factors for childhood malnutrition in Bangladesh". Ann Epidemiol. 3 (4): 382–6. PMID 8275214.
  4. Coulthard MG (2015). "Oedema in kwashiorkor is caused by hypoalbuminaemia". Paediatr Int Child Health. 35 (2): 83–9. doi:10.1179/2046905514Y.0000000154. PMC 4462841. PMID 25223408.
  5. RAO KS, SWAMINATHAN MC, SWARUP S, PATWARDHAN VN (1959). "Protein malnutrition in South India". Bull. World Health Organ. 20: 603–39. PMC 2537781. PMID 14436226.
  6. Barus ST, Rani R, Lubis NU, Hamid ED, Tarigan S (1990). "Clinical features of severe malnutrition at the pediatric ward of Dr. Pirngadi Hospital Medan". Paediatr Indones. 30 (11–12): 286–92. PMID 2077461.
  7. Rodríguez L, Cervantes E, Ortiz R (2011). "Malnutrition and gastrointestinal and respiratory infections in children: a public health problem". Int J Environ Res Public Health. 8 (4): 1174–205. doi:10.3390/ijerph8041174. PMC 3118884. PMID 21695035.
  8. Latham MC (1991). "The dermatosis of kwashiorkor in young children". Semin Dermatol. 10 (4): 270–2. PMID 1764353.
  9. McLaren DS (1987). "Skin in protein energy malnutrition". Arch Dermatol. 123 (12): 1674–1676a. PMID 3120652.
  10. Jaya Rao KS, Srikantia SG, Gopalan C (1968). "Plasma cortisol levels in protein-calorie malnutrition". Arch. Dis. Child. 43 (229): 365–7. PMC 2019952. PMID 4297407.
  11. Muniz-Junqueira MI, Queiroz EF (2002). "Relationship between protein-energy malnutrition, vitamin A, and parasitoses in living in Brasília". Rev. Soc. Bras. Med. Trop. 35 (2): 133–41. PMID 12011921.
  12. Donnen P, Brasseur D, Dramaix M, Vertongen F, Ngoy B, Zihindula M, Hennart P (1996). "Vitamin A deficiency and protein-energy malnutrition in a sample of pre-school age children in the Kivu Province in Zaire". Eur J Clin Nutr. 50 (7): 456–61. PMID 8862482.
  13. Cho EJ, Kim MY, Lee JH, Lee IY, Lim YL, Choi DH; et al. (2015). "Diagnostic and Prognostic Values of Noninvasive Predictors of Portal Hypertension in Patients with Alcoholic Cirrhosis". PLoS One. 10 (7): e0133935. doi:10.1371/journal.pone.0133935. PMC 4511411. PMID 26196942.
  14. Cuzzoni E, De Iudicibus S, Franca R, Stocco G, Lucafò M, Pelin M; et al. (2015). "Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome". Pharmacogenomics. 16 (14): 1631–48. doi:10.2217/pgs.15.101. PMID 26419298.
  15. DiMagno MJ, DiMagno EP (2013). "Chronic pancreatitis". Curr Opin Gastroenterol. 29 (5): 531–6. doi:10.1097/MOG.0b013e3283639370. PMC 4387887. PMID 23852141.
  16. Keithley JK, Swanson B (2013). "HIV-associated wasting". J Assoc Nurses AIDS Care. 24 (1 Suppl): S103–11. doi:10.1016/j.jana.2012.06.013. PMID 23290370.
  17. Nahlen BL, Chu SY, Nwanyanwu OC, Berkelman RL, Martinez SA, Rullan JV (1993). "HIV wasting syndrome in the United States". AIDS. 7 (2): 183–8. PMID 8466680.
  18. Vogelaar JL, Loar RW, Bram RJ, Fischer PR, Kaushik R (2014). "Anasarca, hypoalbuminemia, and anemia: what is the correlation?". Clin Pediatr (Phila). 53 (7): 710–2. doi:10.1177/0009922814526990. PMID 24647692.
  19. Amiot A (2015). "[Protein-losing enteropathy]". Rev Med Interne. 36 (7): 467–73. doi:10.1016/j.revmed.2014.12.001. PMID 25618488.
  20. Ramírez Prada D, Delgado G, Hidalgo Patiño CA, Pérez-Navero J, Gil Campos M (2011). "Using of WHO guidelines for the management of severe malnutrition to cases of marasmus and kwashiorkor in a Colombia children's hospital". Nutr Hosp. 26 (5): 977–83. doi:10.1590/S0212-16112011000500009. PMID 22072341.
  21. "Epidemiology and Prevention of Vaccine-Preventable Diseases".

Template:WH Template:WS